Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants

BackgroundIntracerebral hemorrhage (ICH) is a life-threatening complication of non-vitamin K antagonist oral anticoagulants (NOAC). Little is known about the effect of intensity of anticoagulation on NOAC-ICH. We describe the current use of coagulation testing in the emergency setting and explore as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Purrucker, Jan (VerfasserIn) , Rizos, Timolaos (VerfasserIn) , Wolf, Marcel (VerfasserIn) , Khan, Shujah (VerfasserIn) , Veltkamp, Roland (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 5 May 2017
In: Neurocritical care
Year: 2017, Jahrgang: 27, Heft: 2, Pages: 208-213
ISSN:1556-0961
DOI:10.1007/s12028-017-0403-x
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s12028-017-0403-x
Verlag, Volltext: https://doi.org/10.1007/s12028-017-0403-x
Volltext
Verfasserangaben:Jan C. Purrucker, Timolaos Rizos, Kirsten Haas, Marcel Wolf, Shujah Khan, Peter U. Heuschmann, Roland Veltkamp, on behalf of the RASUNOA investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1582215553
003 DE-627
005 20230427193153.0
007 cr uuu---uuuuu
008 181023s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s12028-017-0403-x  |2 doi 
035 |a (DE-627)1582215553 
035 |a (DE-576)512215553 
035 |a (DE-599)BSZ512215553 
035 |a (OCoLC)1341020502 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Purrucker, Jan  |d 1982-  |e VerfasserIn  |0 (DE-588)142755281  |0 (DE-627)638930405  |0 (DE-576)333199219  |4 aut 
245 1 0 |a Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants  |c Jan C. Purrucker, Timolaos Rizos, Kirsten Haas, Marcel Wolf, Shujah Khan, Peter U. Heuschmann, Roland Veltkamp, on behalf of the RASUNOA investigators 
264 1 |c 5 May 2017 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.10.2018 
520 |a BackgroundIntracerebral hemorrhage (ICH) is a life-threatening complication of non-vitamin K antagonist oral anticoagulants (NOAC). Little is known about the effect of intensity of anticoagulation on NOAC-ICH. We describe the current use of coagulation testing in the emergency setting and explore associations with baseline size and expansion of hematoma as determined in a previous study.MethodsData from the prospective multicenter RASUNOA registry were analyzed. Patients with NOAC-ICH were enrolled between February 2012 and December 2014. Frequency of local test performance of specific (anti-factor Xa tests, diluted thrombin time) and non-specific tests (international normalized ratio (INR), activated partial thromboplastin time (aPTT), thrombin time) was analyzed. The association of anticoagulation intensity at admission with hematoma volume and hematoma expansion was explored.ResultsIn 61 NOAC-ICH patients enrolled at 21 centers, drug-specific coagulation testing was performed in 16 cases (26%), and only 29% of centers appeared to use drug-specific tests in NOAC-ICH at all. In some cases, INR and aPTT values were normal despite drug concentrations in the peak range. In patients with available drug-specific concentrations, 50% had drug levels in the peak range at admission. Higher intensity of anticoagulation was not associated with higher hematoma volume at admission or with subsequent hematoma expansion.ConclusionDrug-specific tests are only infrequently used in NOAC-ICH. Normal results in non-specific coagulation do not reliably rule out peak range concentrations. Anticoagulation intensity at admission does not predict baseline hematoma volume or subsequent hematoma expansion. 
650 4 |a Anticoagulation 
650 4 |a Intracerebral hemorrhage 
650 4 |a Laboratory testing 
650 4 |a Oral anticoagulants 
650 4 |a Stroke 
700 1 |a Rizos, Timolaos  |d 1973-  |e VerfasserIn  |0 (DE-588)129478458  |0 (DE-627)470187891  |0 (DE-576)297680536  |4 aut 
700 1 |a Wolf, Marcel  |e VerfasserIn  |0 (DE-588)140366040  |0 (DE-627)618253777  |0 (DE-576)316608556  |4 aut 
700 1 |a Khan, Shujah  |e VerfasserIn  |0 (DE-588)1169687792  |0 (DE-627)1035290324  |0 (DE-576)51219887X  |4 aut 
700 1 |a Veltkamp, Roland  |d 1966-  |e VerfasserIn  |0 (DE-588)172858453  |0 (DE-627)697787567  |0 (DE-576)133713997  |4 aut 
773 0 8 |i Enthalten in  |t Neurocritical care  |d New York, NY : Springer, 2004  |g 27(2017), 2, Seite 208-213  |h Online-Ressource  |w (DE-627)478509855  |w (DE-600)2176033-0  |w (DE-576)306831910  |x 1556-0961  |7 nnas  |a Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants 
773 1 8 |g volume:27  |g year:2017  |g number:2  |g pages:208-213  |g extent:6  |a Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants 
856 4 0 |u http://dx.doi.org/10.1007/s12028-017-0403-x  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://doi.org/10.1007/s12028-017-0403-x  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181023 
993 |a Article 
994 |a 2017 
998 |g 172858453  |a Veltkamp, Roland  |m 172858453:Veltkamp, Roland  |d 910000  |d 911100  |e 910000PV172858453  |e 911100PV172858453  |k 0/910000/  |k 1/910000/911100/  |p 6 
998 |g 1169687792  |a Khan, Shujah  |m 1169687792:Khan, Shujah  |d 910000  |d 911100  |e 910000PK1169687792  |e 911100PK1169687792  |k 0/910000/  |k 1/910000/911100/  |p 5 
998 |g 140366040  |a Wolf, Marcel  |m 140366040:Wolf, Marcel  |d 910000  |d 911100  |e 910000PW140366040  |e 911100PW140366040  |k 0/910000/  |k 1/910000/911100/  |p 4 
998 |g 129478458  |a Rizos, Timolaos  |m 129478458:Rizos, Timolaos  |d 910000  |d 911100  |e 910000PR129478458  |e 911100PR129478458  |k 0/910000/  |k 1/910000/911100/  |p 2 
998 |g 142755281  |a Purrucker, Jan  |m 142755281:Purrucker, Jan  |d 910000  |d 911100  |e 910000PP142755281  |e 911100PP142755281  |k 0/910000/  |k 1/910000/911100/  |p 1  |x j 
999 |a KXP-PPN1582215553  |e 3029522768 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"5 May 2017","dateIssuedKey":"2017"}],"name":{"displayForm":["Jan C. Purrucker, Timolaos Rizos, Kirsten Haas, Marcel Wolf, Shujah Khan, Peter U. Heuschmann, Roland Veltkamp, on behalf of the RASUNOA investigators"]},"id":{"eki":["1582215553"],"doi":["10.1007/s12028-017-0403-x"]},"recId":"1582215553","type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"display":"Purrucker, Jan","role":"aut","family":"Purrucker","given":"Jan"},{"given":"Timolaos","display":"Rizos, Timolaos","family":"Rizos","role":"aut"},{"display":"Wolf, Marcel","family":"Wolf","role":"aut","given":"Marcel"},{"given":"Shujah","role":"aut","family":"Khan","display":"Khan, Shujah"},{"family":"Veltkamp","role":"aut","display":"Veltkamp, Roland","given":"Roland"}],"note":["Gesehen am 23.10.2018"],"language":["eng"],"physDesc":[{"extent":"6 S."}],"title":[{"title":"Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants","title_sort":"Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulants"}],"relHost":[{"pubHistory":["1.2004 -"],"note":["Gesehen am 11.09.14"],"language":["eng"],"id":{"issn":["1556-0961"],"zdb":["2176033-0"],"eki":["478509855"]},"recId":"478509855","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Coagulation testing in intracerebral hemorrhage related to non-vitamin K antagonist oral anticoagulantsNeurocritical care","origin":[{"publisherPlace":"New York, NY ; Totowa, NJ","dateIssuedKey":"2004","dateIssuedDisp":"2004-","publisher":"Springer ; Humana Press"}],"name":{"displayForm":["Neurocritical Care Society"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Neurocritical care","title":"Neurocritical care"}],"part":{"text":"27(2017), 2, Seite 208-213","volume":"27","pages":"208-213","year":"2017","issue":"2","extent":"6"}}]} 
SRT |a PURRUCKERJCOAGULATIO5201